People · Operator

Richard Schmitt

Named in public records as an officer, director or promoter · active 2013–2025 · Other Health Care, Electric Utilities

2
Companies
2
Filings
$4.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
EpiWatch, Inc.Other Health CarePre-Seed$2.9M$1.7M2025
Dr2, LlcElectric UtilitiesSeed$1.4M$14.3M2013
Operator network

Richard Schmitt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Robert Smith · 17 companies · 1 sharedRobert SmithRichard Thomas · 3 companies · 1 sharedRichard ThomasMichael E. Singer · 2 companies · 1 sharedMichael E. SingerRobert E. Smith · 2 companies · 1 sharedRobert E. SmithDaniel Hanley · 1 companies · 1 sharedDaniel HanleyDean Papadopoulos · 1 companies · 1 sharedDean PapadopoulosGregory Krauss · 1 companies · 1 sharedGregory KraussNathan Crone · 1 companies · 1 sharedNathan CroneRichard E. Schmitt · 1 companies · 1 sharedRichard E. SchmittTeresa E. Prego · 1 companies · 1 sharedTeresa E. PregoTeresa Prego · 1 companies · 1 sharedTeresa PregoMalcolm Smith · 4 companies · 1 sharedMalcolm SmithThomas Balderston · 4 companies · 1 sharedThomas BalderstonEpiWatch, Inc. · $2.9M raisedEpiWatch, Inc.Dr2, Llc · $1.4M raisedDr2, LlcRichard SchmittRS
Richard Schmitt Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Richard Schmitt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Robert Smith117
Thomas Balderston14
Malcolm Smith14
Richard Thomas13
Michael E. Singer12
Robert E. Smith12
Richard E. Schmitt11
Teresa Prego11
Gregory Krauss11
Nathan Crone11
Teresa E. Prego11
Dean Papadopoulos11
Daniel Hanley11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.